PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES-Reference-Cited by-同舟云学术

PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES

Published:2019-12-24 Issue: Volume:57 Page:1-40
ISSN:1995-4492
Container-title:Rheumatology Science and Practice
language:
Short-container-title:Naučno-praktičeskaâ revmatologiâ

Author:

Nasonov E L.¹,Beketova T. V.²,Ananyeva L. P.²,Vasilyev V. I.²,Solovyev S. K.²,Avdeeva A. S.²

Affiliation:

1. V.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

2. V.A. Nasonova Research Institute of Rheumatology

Publisher

Mediar Press

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference558 articles.

1. Kaplan B, Kopyltsova Y, Khokhar A, et al. Rituximab and immune deficiency: case series and review of the literature. J Allergy Clin Immunol Pract. 2014;2:594-600. doi: 10.1016/j.jaip.2014.06.003

2. Deodhar A, Isaacs J, Rigby W, et al. Improved quality of life (QoL) with rituximab (RTX) as first-line biologic therapy in patients (pts) with active rheumatoid arthritis (RA): results from a phase III randomized controlled study (SERENE) [abstract]. Arthritis Rheum. 2008;58 Suppl:S302.

3. Hua Chen, Wenjie Zheng, Jinmei Su, et al. Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus – a prospective pilot study. Rheumatology (Oxford). 2011;50(9):1640-4. doi: 10.1093/rheumatology/ker176

4. Nasonov EL, Aleksandrova EN, Novikov AA. Autoimmune rheumatic diseases – problems of immunopathology and personalized therapy. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2015;70(2):169-82 (In Russ.).

5. Kobelt G, Kasteng F. Access to Innovative Treatments in Rheumatoid Arthritis in Europe. 2009. Available at: http://www.comparatorreports.se/Access to MS treatments - October 2009.pdf

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Belimumab in the treatment of systemic lupus erythematosus with juvenile onset: Results of a single-center retrospective study;Rheumatology Science and Practice;2024-09-02

2. Modern treatment options for systemic lupus erythematosus in children (literature review);Modern Rheumatology Journal;2024-08-21

3. Pharmacotherapy of autoimmune rheumatic diseases – from monoclonal antibodies to CAR T cells: 20 years later;Rheumatology Science and Practice;2024-06-26

4. The Use of “Acellbia”—A Biosimilar of Rituximab in Systemic Sclerosis;Doklady Biochemistry and Biophysics;2024-06-10

5. Safety and Tolerability of Rituximab in the Treatment of Systemic Sclerosis;Doklady Biochemistry and Biophysics;2024-06-10